Quidel Cp (QDEL) |
|
99.11 -3.5 (-3.41%)
|
01-26 01:00 |
|
Open: |
102.13 |
Pre. Close: |
102.61 |
|
High:
|
102.75 |
Low:
|
96.81 |
|
Volume:
|
1,250,649 |
Market Cap:
|
4,131M |
|
|
|
|
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
102.904 - 103.623 |
103.623 - 104.175 |
|
Low:
|
94.993 - 95.935 |
95.935 - 96.658 |
|
Close:
|
97.789 - 99.082 |
99.082 - 100.074 |
|
Technical analysis |
as of: 2022-01-25 4:26:39 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 172.88 One year: 210.31 |
| Support: |
Support1: 96.18 Support2: 80.02 |
| Resistance: |
Resistance1: 148.02 Resistance2: 180.06 |
| Pivot: |
117.17  |
| Moving Average: |
MA(5): 105.69 MA(20): 120.74
MA(100): 137.04 MA(250): 136.76 |
| MACD: |
MACD(12,26): -9.83 Signal(9): -7.60 |
| Stochastic oscillator: |
%K(14,3): 8.14  %D(3): 6.40 |
| RSI: |
RSI(14): 27.60 |
| 52-week: |
High: 258.49 Low: 96.18 Change(%): -60.5 |
| Average Vol(K): |
3-Month: 809 10-Days: 842 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.QDEL has closed above bottom band by 4.6%. Bollinger Bands are 29.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Outperform |
Price to Earnings: |
Outperform |
| Return on Equity: |
Outperform |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
42 |
| Shares Float (M) |
38 |
|
% Held by Insiders
|
12.11 |
|
% Held by Institutions
|
87.52 |
|
Shares Short (K)
|
3,520 |
|
Shares Short P. Month (K)
|
3,580 |
Stock Financials |
|
EPS
|
20.650 |
|
EPS Est This Year
|
0.290 |
|
EPS Est Next Year
|
1.260 |
|
Book Value (p.s.)
|
39.210 |
|
Profit Margin
|
47.20 |
|
Operating Margin
|
61.48 |
|
Return on Assets (ttm)
|
42.8 |
|
Return on Equity (ttm)
|
71.1 |
|
Qtrly Rev. Growth
|
7.1 |
|
Gross Profit (p.s.)
|
32.382 |
|
Sales Per Share
|
44.855 |
|
EBITDA (p.s.)
|
28.784 |
|
Qtrly Earnings Growth
|
-7.10 |
|
Operating Cash Flow (M)
|
924 |
|
Levered Free Cash Flow (M)
|
511 |
Stock Valuations |
|
PE Ratio
|
4.80 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.53 |
|
Price to Sales
|
2.21 |
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
